0000899243-20-020385.txt : 20200724
0000899243-20-020385.hdr.sgml : 20200724
20200724164052
ACCESSION NUMBER: 0000899243-20-020385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200722
FILED AS OF DATE: 20200724
DATE AS OF CHANGE: 20200724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Norkunas Matthew
CENTRAL INDEX KEY: 0001816836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39319
FILM NUMBER: 201047313
MAIL ADDRESS:
STREET 1: C/O GENERATION BIO CO.
STREET 2: 301 BINNEY STREET, SUITE 401
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Generation Bio Co.
CENTRAL INDEX KEY: 0001733294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 814301281
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-529-5908
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-22
0
0001733294
Generation Bio Co.
GBIO
0001816836
Norkunas Matthew
C/O GENERATION BIO CO.,
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
21.41
2020-07-22
4
A
0
330000
0.00
A
2030-07-21
Common Stock
330000
330000
D
The option was granted on July 22, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on July 22, 2021 and the remaining shares vesting in equal quarterly installments thereafter.
/s/ Jennifer Elliott, Attorney-in-Fact
2020-07-24